Page last updated: 2024-08-22

cladribine and Granulomatosis, Lipid

cladribine has been researched along with Granulomatosis, Lipid in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (13.33)29.6817
2010's9 (60.00)24.3611
2020's4 (26.67)2.80

Authors

AuthorsStudies
Adam, Z; Brychtová, M; Gregorová, J; Krejčí, M; Ševčíková, S; Vlachová, M1
Lahlimi, F; Lasri, N; Tazi, MI1
Kasahara, I; Sakai, T; Wada, N; Yamaguchi, K; Yamamoto, S1
Adam, Z; Koukalová, R; Král, Z; Krejčí, M; Pour, L; Řehák, Z; Sandecká, V; Ševčíková, S; Štork, M1
Kasami, T; Katagiri, T; Kawamoto, K; Kobayashi, H; Masuko, M; Miyakoshi, S; Miyoshi, H; Nemoto, H; Ohshima, K; Shibasaki, Y; Sone, H; Suzuki, T; Takeuchi, K; Takizawa, J; Tamura, S1
Manevich-Mazor, M; Mazor, RD; Shoenfeld, Y1
Aizenstein, O; Eshed, I; Ganzel, C; Goldberg, I; Gural, A; Jaffe, R; Kesler, A; Manevich-Mazor, M; Mazor, RD; Pessach, Y; Shoenfeld, Y; Sprecher, E; Yaish, I1
Blomstrand, L; Hagberg, H; Thor, A1
Antić, B; Jovandić, S; Knezević-Usaj, S; Magić, Z; Perić, P; Radić-Tasić, O; Radovinović-Tasić, S; Sekulović, L; Tarabar, O; Tukić, L; Vasić-Vilić, J1
Call, TG; Go, RS; Goyal, G; Hogan, WJ; Litzow, MR; Shah, MV1
Aouba, A; Guillevin, L; Larousserie, F; Le Guern, V; Martin, A1
Alharthi, MS; Appleton, C; Calleja, A; Jaroszewski, DE; Mookadam, F; Panse, P; Tazelaar, HD1
Adam, Z; Cervinek, L; Chaloupka, R; Hájek, R; Koukalová, R; Krejcí, M; Mayer, J; Moulis, M; Pour, L; Prásek, J; Rehák, Z; Sprláková, A; Szturz, P; Zahradová, L1
Adam, Z; Cervinek, L; Hájek, R; Hermanová, M; Koukalová, R; Král, Z; Krejcí, M; Kren, L; Mayer, J; Mechl, M; Moulis, M; Pour, L; Prásek, J; Rehák, Z; Sprláková, A; Szturz, P; Zahradová, L1
Gregson, RH; Haynes, AP; McIntosh, RS; Myra, C; Powell, RJ; Sloper, L; Sokal, M; Stevens, SE; Tighe, PJ1

Reviews

4 review(s) available for cladribine and Granulomatosis, Lipid

ArticleYear
Erdheim-Chester disease.
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2021,Fall, Volume: 34, Issue:6

    Topics: Cladribine; Erdheim-Chester Disease; Humans; Interferon-alpha; Interleukin 1 Receptor Antagonist Protein; MTOR Inhibitors; Protein Kinase Inhibitors

2021
Erdheim-Chester Disease: a comprehensive review of the literature.
    Orphanet journal of rare diseases, 2013, Sep-08, Volume: 8

    Topics: Cladribine; Erdheim-Chester Disease; Humans; Indoles; Interferon-alpha; Interleukin 1 Receptor Antagonist Protein; Sulfonamides; Vemurafenib

2013
[Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review].
    Vnitrni lekarstvi, 2011, Volume: 57, Issue:6

    Topics: Antineoplastic Agents; Cladribine; Cyclophosphamide; Erdheim-Chester Disease; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed

2011
Treatment of Erdheim-Chester disease with cladribine: a rational approach.
    The British journal of ophthalmology, 2004, Volume: 88, Issue:6

    Topics: Cladribine; Cytokines; Erdheim-Chester Disease; Humans; Immunosuppressive Agents; Male; Middle Aged

2004

Other Studies

11 other study(ies) available for cladribine and Granulomatosis, Lipid

ArticleYear
[Erdheim-Chester disease: an aggressive systemic disease treated with cladribine with favorable outcome (a case report)].
    The Pan African medical journal, 2022, Volume: 42

    Topics: Cerebellar Ataxia; Cladribine; Erdheim-Chester Disease; Humans; Male; Middle Aged; Radiography; Tomography, X-Ray Computed

2022
[Refractory Erdheim-Chester disease with central nervous system lesion complicated by central diabetes insipidus].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2020, Volume: 61, Issue:10

    Topics: Central Nervous System; Central Nervous System Diseases; Cladribine; Diabetes Insipidus, Neurogenic; Erdheim-Chester Disease; Female; Humans; Middle Aged; Tomography, X-Ray Computed

2020
Therapy of 3 patients with Erdhiem-Chester disease with cladribin or cladribin in combination with cyclophosphamide. Case report and review of the therapy.
    Vnitrni lekarstvi, 2021,Summer, Volume: 67, Issue:3

    Topics: Adult; Cladribine; Cyclophosphamide; Erdheim-Chester Disease; Humans; Interleukin 1 Receptor Antagonist Protein; Remission Induction

2021
Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.
    Journal of clinical and experimental hematopathology : JCEH, 2018, Dec-13, Volume: 58, Issue:4

    Topics: Aged; Amino Acid Substitution; Central Nervous System Diseases; Cladribine; Erdheim-Chester Disease; Humans; Janus Kinase 2; Male; Mutation, Missense; Polycythemia Vera; Proto-Oncogene Proteins B-raf

2018
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.
    BMC medicine, 2014, Dec-01, Volume: 12

    Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents; Biopsy; Cladribine; Erdheim-Chester Disease; Female; Humans; Indoles; Infliximab; Interferons; Male; Middle Aged; Mutation; Proto-Oncogene Proteins B-raf; Sulfonamides; Vemurafenib

2014
Erdheim-Chester disease presenting as periodontal disease: Experience of treatment with cladribine, interferon-a, local radiotherapy and anakinra.
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:2

    Topics: Adult; Cladribine; Erdheim-Chester Disease; Humans; Interferon-alpha; Interleukin 1 Receptor Antagonist Protein; Male; Periodontal Diseases

2016
Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Vojnosanitetski pregled, 2016, Volume: 73, Issue:1

    Topics: Adult; Antineoplastic Agents; Biomarkers; Cladribine; Diabetes Insipidus; Dose-Response Relationship, Drug; Erdheim-Chester Disease; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Mutation; Orbital Pseudotumor; Proto-Oncogene Proteins B-raf; Treatment Outcome

2016
Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease.
    JAMA oncology, 2017, Sep-01, Volume: 3, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Disease Progression; Erdheim-Chester Disease; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Young Adult

2017
Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review.
    Joint bone spine, 2009, Volume: 76, Issue:6

    Topics: Adult; Cladribine; Erdheim-Chester Disease; Hip Joint; Histiocytes; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Lymph Nodes; Male; Osteoarthritis; Radiography; Synovial Membrane; Treatment Outcome

2009
Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease.
    European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2010, Volume: 11, Issue:7

    Topics: Aorta; Cladribine; Erdheim-Chester Disease; Female; Heart Atria; Heart Diseases; Heart Ventricles; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Middle Aged; Myocardium; Pericardial Effusion; Pericardiocentesis; Tomography, X-Ray Computed; Treatment Outcome

2010
[Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2011, Volume: 24, Issue:5

    Topics: Adult; Bone Marrow; Brain; Cladribine; Erdheim-Chester Disease; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Radiography, Abdominal; Remission Induction; Thalidomide; Tomography, X-Ray Computed

2011